Simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase inhibitor, exhibits inhibitory effects on the cell growth of hormone-refractory PCa PC3 and DU-145 cells by inhibiting the NF-κB pathway. The gene discussed is NFKB1; the disease is posterior cortical atrophy.